Table 2.
Variable analysis | Overall Survival | Disease-Free Survival | ||||
---|---|---|---|---|---|---|
|
|
|||||
HR | 95% CI | p | HR | 95% CI | p | |
Univariate | N = 405 | N = 405 | ||||
FGG | 7.137 | 4.196-12.141 | < 0.001 | 6.080 | 3.932-9.401 | < 0.001 |
Multivariate | N = 405 | N = 405 | ||||
Age | 0.854 | 0.494-1.478 | 0.573 | 1.063 | 0.683-1.656 | 0.786 |
Size | 1.221 | 0.664-2.245 | 0.521 | 1.641 | 0.953-2.826 | 0.074 |
Stage | 0.989 | 0.667-1.467 | 0.957 | 0.907 | 0.663-1.241 | 0.541 |
Grade | 0.399 | 0.195-0.816 | 0.012 | 0.776 | 0.431-1.400 | 0.400 |
Lymph | 1.368 | 0.721-2.596 | 0.337 | 1.157 | 0.653-2.049 | 0.617 |
ER | 0.716 | 0.344-1.490 | 0.372 | 0.611 | 0.339-1.102 | 0.101 |
PR | 0.848 | 0.424-1.694 | 0.640 | 0.769 | 0.437-1.355 | 0.364 |
HER2 | 1.132 | 0.616-2.080 | 0.690 | 1.040 | 0.683-1.656 | 0.786 |
FGG | 8.641 | 4.738-15.758 | < 0.001 | 5.862 | 3.566-9.634 | < 0.001 |
CI = confidence interval; HR = hazard ratios. The variables were compared in the following ways: Age, ≥ 50 years vs. < 50 years; FGG expression, positive vs. negative; size, > 2 cm vs. < 2 cm; Stage, III-IV vs. I-II; Grade, G3-4 vs. G1-2; Lymph, Yes vs. no; ER, PR, HER2, yes vs. no.